Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Could be ugly tomorrow........
View:
Post by InvestorRights on Mar 05, 2023 8:07pm

Could be ugly tomorrow........

CEO.ca has comments saying that TLT has about 30 days of cash left? Does anyone have any facts? Please shed some light. Very unusual that someone unloads such a large position without knowing something.
Comment by InvestorRights on Mar 05, 2023 8:17pm
From a post on CEO.ca: They definitely need cash asap. My rough calcs assume they run out of cash this month. The hope was BTD could have catalyzed the share price and enable less dilution but it seems likely this weakness is due to an immediate need to shore up another 6 months of operations (another 10M shs at .25?).
Comment by Rumpl3StiltSkin on Mar 06, 2023 9:12am
There is another post on CEO.ca that says they have enuf cash $$ to get to April/May. Even stretch it to Sept/Oct.  Do you believe everything you believe on CEO.ca ?
Comment by InvestorRights on Mar 05, 2023 8:29pm
Depth as of now, let's see how this changes tomorrow..... Time Price Count Size 03/03 $0.33 1 2,500 03/03 $0.32 1 2,500  ...more  
Comment by Oilminerdeluxe on Mar 06, 2023 2:20am
What are you talking about??
Comment by fecats on Mar 06, 2023 9:13am
How do you figure that 157,000 shares is a large position? We have @ 300 million fully diluted . If I saw millions trading I would have concerns.
Comment by Lesalpes29 on Mar 06, 2023 9:18am
Trying to create fear again and again. Clown. GL
Comment by StevenBirch on Mar 06, 2023 9:56am
The first week of every month is the same as the last. Same cast of characters with the same message, some really need to be ignored. Even those who on the surface act like real longs but always seem to chime in and agree like they are just being realists. Once okay, twice maybe but most of us have gotten their message and have chosen for ourselves what we want to do.
Comment by InvestorRights on Mar 06, 2023 10:11am
Nothing wrong with being objective. I love the company and the science, and the potential good it can do, but as an investor I look at both sides, and my concerns are with cheap shares now coming to market with the last few raises at $0.25 and the warrants attached to them at $0.35, there are millions of shares that have been recently unlocked, next is further dilution, the company will need to ...more  
Comment by Rumpl3StiltSkin on Mar 06, 2023 10:45am
Just go away already fake long.. We're on to you.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250